Orthocell Limited (ASX:OCC)

Revenue by Product

Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	NaN - NaN
Regenerative Medicine	3.01M	Log In	Log In	Log In	Log In	Upgrade
Regenerative Medicine Growth	55.30%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	NaN - NaN
Australia	3.01M	Log In	Log In	Log In	Log In	Upgrade
Australia Growth	55.30%	Log In	Log In	Log In	Log In	Upgrade